1. Home
  2. SLGL vs DSY Comparison

SLGL vs DSY Comparison

Compare SLGL & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • DSY
  • Stock Information
  • Founded
  • SLGL 1997
  • DSY 2020
  • Country
  • SLGL Israel
  • DSY China
  • Employees
  • SLGL N/A
  • DSY N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • DSY
  • Sector
  • SLGL Health Care
  • DSY
  • Exchange
  • SLGL Nasdaq
  • DSY Nasdaq
  • Market Cap
  • SLGL 69.1M
  • DSY 57.6M
  • IPO Year
  • SLGL 2018
  • DSY N/A
  • Fundamental
  • Price
  • SLGL $23.98
  • DSY $1.61
  • Analyst Decision
  • SLGL
  • DSY
  • Analyst Count
  • SLGL 0
  • DSY 0
  • Target Price
  • SLGL N/A
  • DSY N/A
  • AVG Volume (30 Days)
  • SLGL 33.1K
  • DSY 3.9M
  • Earning Date
  • SLGL 11-14-2025
  • DSY 01-01-0001
  • Dividend Yield
  • SLGL N/A
  • DSY N/A
  • EPS Growth
  • SLGL N/A
  • DSY 120.37
  • EPS
  • SLGL N/A
  • DSY 0.01
  • Revenue
  • SLGL $23,931,000.00
  • DSY $7,323,356.00
  • Revenue This Year
  • SLGL N/A
  • DSY N/A
  • Revenue Next Year
  • SLGL $31.17
  • DSY N/A
  • P/E Ratio
  • SLGL N/A
  • DSY $144.47
  • Revenue Growth
  • SLGL 264.86
  • DSY 16.37
  • 52 Week Low
  • SLGL $4.01
  • DSY $0.95
  • 52 Week High
  • SLGL $30.00
  • DSY $7.33
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 58.56
  • DSY 55.08
  • Support Level
  • SLGL $23.13
  • DSY $1.51
  • Resistance Level
  • SLGL $24.85
  • DSY $7.33
  • Average True Range (ATR)
  • SLGL 2.36
  • DSY 0.47
  • MACD
  • SLGL -0.43
  • DSY 0.08
  • Stochastic Oscillator
  • SLGL 39.19
  • DSY 9.92

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.

Share on Social Networks: